Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer

Clinical trial NCT00003880 · TERMINATED

Trial details

NCT number: NCT00003880
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Ovarian Cancer Primary Peritoneal Cavity Cancer

Start date: 1999-02-01
Primary completion: 2001-08-01
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.